Average Co-Inventor Count = 5.77
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (20 from 1,149 patents)
2. The University of Newcastle Upon Tyne (1 from 60 patents)
20 patents:
1. 11464774 - Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
2. 11110086 - Compounds useful as inhibitors of ATR kinase and combination therapies thereof
3. 10961232 - Substituted pyrazines as ATR kinase inhibitors
4. 10813929 - Treating cancer with ATR inhibitors
5. 10478430 - Compounds useful as inhibitors of ATR kinase and combination therapies thereof
6. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase
7. 9791456 - Method for measuring ATR inhibition mediated increases in DNA damage
8. 9701674 - Substituted pyrazines as ATR kinase inhibitors
9. 9630956 - Compounds useful as inhibitors of ATR kinase
10. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase
11. 9334244 - Compounds useful as inhibitors of ATR kinase
12. 9096584 - Compounds useful as inhibitors of ATR kinase
13. 9062008 - Compounds useful as inhibitors of ATR kinase
14. 8999632 - Method for measuring ATR inhibition mediated increases in DNA damage
15. 8969356 - Compounds useful as inhibitors of ATR kinase